Literature DB >> 28333871

Successful Treatment of Refractory Juvenile Dermatomyositis With Adalimumab.

Chrong-Reen Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28333871     DOI： 10.1097/RHU.0000000000000514

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  4 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

2.  Rare occurrence of inflammatory bowel disease in a cohort of Han Chinese ankylosing spondylitis patients- a single institute study.

Authors:  Chrong-Reen Wang; Chia-Tse Weng; Chung-Ta Lee; Kuo-Yuan Huang; Sheng-Min Hsu; Ming-Fei Liu
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379

Review 3.  Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases.

Authors:  Romy E Hoeppli; Anne M Pesenacker
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

4.  Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis.

Authors:  Zhaoling Wang; Qi Zheng; Wenjie Xuan; Xisheng Xu; Meiping Lu; Jianqiang Wu; Lixia Zou; Yiping Xu; Xuefeng Xu
Journal:  Front Pediatr       Date:  2022-09-20       Impact factor: 3.569
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.